BioNJ Unveils "Time Off for Clinical Trials" Initiative [Yahoo! Finance]
Genmab A/S - American Depositary Shares (GMAB)
Company Research
Source: Yahoo! Finance
Nov. 20, 2024 /PRNewswire/ -- BioNJ New Jersey's life sciences trade association, announced today the successful launch of "Time Off for Clinical Trials" initiative, which encourages BioNJ member organizations to offer their employees paid time off to participate in clinical trials. Companies that have initially committed to implementing this policy within and alongside their existing time off policies include Amicus Therapeutics Bristol Myers Squibb Genmab PsychoGenics PTC Therapeutics and Sanof i "During this year's BioNJ Annual Dinner Meeting and Innovation Celebration in February, Lisa Salberg , Founder and CEO of the Hypertrophic Cardiomyopathy Association (HCMA), delivered a powerful call to action, urging employers to adopt a 'Time Off for Clinical Trials' policy," said BioNJ President and CEO Debbie Hart . "Our Board recognized the need and decided to launch an effort encouraging BioNJ member companies to respond. Acknowledging the essential role clinical trials play in adva
Show less
Read more
Impact Snapshot
Event Time:
GMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMAB alerts
High impacting Genmab A/S - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GMAB
News
- Genmab A/S (NASDAQ: GMAB) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $46.00.MarketBeat
- High Growth Tech Stocks To Watch In November 2024 [Yahoo! Finance]Yahoo! Finance
- Genmab Announces Financial Results for the First Nine Months of 2024 [Yahoo! Finance]Yahoo! Finance
- Genmab Announces Financial Results for the First Nine Months of 2024GlobeNewswire
- Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]Yahoo! Finance